FOMX

Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX

Overview Fund Activity
Delisted

FOMX was delisted on the 6th of March, 2020.

Back to rankings

64 hedge funds and large institutions have $268M invested in Foamix Pharmaceuticals Ltd. Ordinary Shares in 2016 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 16 increasing their positions, 22 reducing their positions, and 8 closing their positions.

Holders
64
Holders Change
+3
Holders Change %
+4.92%
% of All Funds
1.6%
Holding in Top 10
5
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+66.67%
% of All Funds
0.13%
New
11
Increased
16
Reduced
22
Closed
8
Calls
$1.35M
Puts
–
Net Calls
+$1.35M
Net Calls Change
+$381K

Top Buyers

1
O
1
OppenheimerFunds
New York
$7.81M
2
GPP
2
Great Point Partners
Connecticut
$33.3M
3
GTC
3
Ghost Tree Capital
New York
$4.05M
4
Millennium Management
4
Millennium Management
New York
$3.1M
5
IBT
5
International Biotechnology Trust
United Kingdom
$2.2M

Top Sellers

1
Barclays
1
Barclays
United Kingdom
$14K
2
JGC
2
J. Goldman & Co
New York
$1.75M
3
SM
3
Sabby Management
Florida
$648K
4
OM
4
Opaleye Management
Massachusetts
$5.5M
5
FHAM
5
Folger Hill Asset Management
New York
$4.32M
Name Market Value Shares Shares
Change 		Shares
Change %
GPP
1
Great Point Partners
Connecticut
$33.3M 3,000,000 +230,575 +8%
BBA
2
Baker Bros. Advisors
New York
$27.4M 2,466,702 – –
RCM
3
RA Capital Management
Massachusetts
$20.2M 1,820,138 – –
DA
4
DSC Advisors
Illinois
$17.3M 1,560,000 -107,377 -6%
Franklin Resources
5
Franklin Resources
California
$17.1M 1,539,270 – –
MMH
6
Menora Mivtachim Holdings
Israel
$15M 1,350,847 – –
PA
7
Perceptive Advisors
New York
$14.7M 1,322,994 -50,290 -4%
DM
8
Deerfield Management
New York
$13.7M 1,232,844 -74,214 -6%
TCM
9
Tekla Capital Management
Massachusetts
$10.3M 930,398 -35,667 -4%
VC
10
Vivo Capital
California
$9.49M 855,000 – –
DCM
11
Driehaus Capital Management
Illinois
$8.86M 798,591 +8,475 +1%
O
12
OppenheimerFunds
New York
$7.81M 703,658 +703,658 New
Axa
13
Axa
France
$7.69M 692,835 – –
Alyeska Investment Group
14
Alyeska Investment Group
Illinois
$7.26M 653,841 +3,716 +0.6%
SAM
15
Senzar Asset Management
New York
$6.12M 550,997 +27,600 +5%
Bank of New York Mellon
16
Bank of New York Mellon
New York
$5.78M 520,486 -3,988 -0.8%
BFA
17
BlackRock Fund Advisors
California
$5.68M 511,799 +100,072 +24%
OM
18
Opaleye Management
Massachusetts
$5.5M 495,000 -135,000 -21%
FHAM
19
Folger Hill Asset Management
New York
$4.32M 389,586 -123,409 -24%
GTC
20
Ghost Tree Capital
New York
$4.05M 365,000 +207,038 +131%
SFM
21
Sphera Funds Management
Israel
$3.8M 342,000 – –
Millennium Management
22
Millennium Management
New York
$3.1M 279,391 +204,054 +271%
DCM
23
DAFNA Capital Management
California
$2.98M 268,067 -10,000 -4%
Baillie Gifford & Co
24
Baillie Gifford & Co
United Kingdom
$2.44M 219,400 – –
IBT
25
International Biotechnology Trust
United Kingdom
$2.2M 197,838 +197,838 New
1
2 3